IDEAYA Biosciences Announces First Patient Dosing of PKC inhibitor IDE196 in Phase 1/2 Tissue-Type Agnostic Basket Trial for Solid Tumors Harboring GNAQ or GNA11 Mutations

News
2019
2018
Archive

July 12, 2019

IDEAYA Biosciences Announces First Patient Dosing of PKC inhibitor IDE196 in Phase 1/2 Tissue-Type Agnostic Basket Trial for Solid Tumors Harboring GNAQ or GNA11 Mutations
July 12, 2019

Kinestral Technologies’ Halio Cloud Becomes the First Globally Deployed Smart Window Control System
June 25, 2019

Arvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer
June 20, 2019

Nouscom Demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in Combination with Immune Checkpoint Blockade to Eradicate Large Tumors
June 20, 2019

Entrada Therapeutics Appoints John F. Crowley to Board of Directors
June 19, 2019

Kinestral Technologies Partners with Vitrum Glass Group to Produce Halio Smart-Tinting Insulating Glass Units
June 18, 2019

Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names World-Renowned Scientist Lynne E. Maquat, Ph.D., to its Scientific Advisory Board
June 12, 2019

Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
June 10, 2019

Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU and Expects Initial Clinical Results by Year End 2019
June 6, 2019

“Meet the Man Who’s Talking On the Emperor of All Maladies: Cancer”

1
2
3
…
51
Next Page »